Elie Azoulay
Overview
Explore the profile of Elie Azoulay including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
719
Citations
21488
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rouze A, Povoa P, Martin-Loeches I, Saura O, Maizel J, Pouly O, et al.
Respir Res
. 2025 Mar;
26(1):83.
PMID: 40045262
Background: The management of severe SARS-CoV-2 pneumonia, alongside logistical constraints, evolved between the first and subsequent COVID-19 waves. This study aimed to compare the prevalence of early bacterial pulmonary co-infections...
2.
Yvin E, Kouatchet A, Mokart D, Martin-Loeches I, Taccone F, Pene F, et al.
Crit Care Med
. 2025 Feb;
PMID: 40013850
Objectives: Acute hypoxemic respiratory failure in immunocompromised patients remains the leading cause of admission to the ICU, with high case fatality. The response to the initial oxygenation strategy may be...
3.
Barbier F, Buetti N, Dupuis C, Schwebel C, Azoulay E, Argaud L, et al.
Crit Care Med
. 2025 Feb;
PMID: 40009040
Objectives: To evaluate whether early appropriate antimicrobial therapy (EAAT) is associated with improved outcomes in critically ill patients with hospital-acquired pneumonia (HAP), ventilated HAP (vHAP), or ventilator-associated pneumonia (VAP) involving...
4.
Windsor C, Joseph A, Pons S, Mokart D, Pene F, Kouatchet A, et al.
J Intensive Med
. 2025 Jan;
5(1):64-69.
PMID: 39872834
Background: Cancer patients who are exposed to sepsis and had previous chemotherapy may have increased severity. Among chemotherapeutic agents, anthracyclines have been associated with cardiac toxicity. Like other chemotherapeutic agents,...
5.
Friol A, Dumas G, Pene F, Demoule A, Kouatchet A, Argaud L, et al.
Intensive Care Med
. 2025 Jan;
51(1):72-81.
PMID: 39853358
Purpose: Invasive pulmonary aspergillosis (IPA) is a life-threatening opportunistic infection in immunocompromised patients. The diagnosis is often made late, with mortality reaching 90% when mechanical ventilation is needed. We sought...
6.
Chean D, Luque-Paz D, Poole D, Fodil S, Lengline E, Dupont T, et al.
Ann Intensive Care
. 2025 Jan;
15(1):9.
PMID: 39821042
Background: To describe the use of life-sustaining therapies and mortality in patients with acute leukemia admitted to the intensive care unit (ICU). Methods: The PubMed database was searched from January...
7.
Thy M, Sonneville R, Ruckly S, Mourvillier B, Schwebel C, Cohen Y, et al.
J Intensive Care
. 2025 Jan;
13(1):5.
PMID: 39810227
Background: Sepsis-associated encephalopathy (SAE) may be worsened by early systemic insults. We aimed to investigate the association of early systemic insults with outcomes of critically ill patients with severe SAE....
8.
Azoulay E, Barnes N, Nainan-Myatra S, Myatra S, Delgado M, Arabi Y, et al.
Intensive Care Med Exp
. 2025 Jan;
13(1):2.
PMID: 39776054
No abstract available.
9.
Fernandez S, Castro P, Azoulay E
Intensive Care Med
. 2025 Jan;
51(1):39-61.
PMID: 39774866
Purpose: Advances in therapeutic care are leading to an increase in the number of patients living with overt immunosuppression. These patients are at risk of cytomegalovirus (CMV) infection and disease...
10.
Dumas G, Lavillegrand J, Azoulay E
Intensive Care Med
. 2025 Jan;
PMID: 39774859
No abstract available.